Botanix expresses thanks to valued shareholders and other significant contributors to the success of Sofdra® (sofpironium) in the Chairman’s Address presented at the Annual General Meeting. As previously announced, the meeting will be held on 20 November 2025, at 9.30 am (AWST) in the offices of BDO, Level 9, Mia Yellagonga Tower 2, 5 Spring Street in Perth.
Three Sofdra scientific posters were accepted and exhibited at leading dermatology continuing medical education (CME) conferences in October and early November 2025. CME is a trusted source of information for dermatologists.
We share the International Hyperhidrosis Society’s belief that ‘together, we can amplify the message that excessive, uncontrollable sweating is a serious medical condition warranting serious attention.’ Throughout November, Botanix will introduce new materials in dermatology offices to raise awareness of excessive underarm sweating and Sofdra® (sofpironium).
